Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605.
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605.
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23). doi: 10.1073/pnas.2024605118.
Profilin-1 (PFN1) plays important roles in modulating actin dynamics through binding both monomeric actin and proteins enriched with polyproline motifs. Mutations in PFN1 have been linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS). However, whether ALS-linked mutations affect PFN1 function has remained unclear. To address this question, we employed an unbiased proteomics analysis in mammalian cells to identify proteins that differentially interact with mutant and wild-type (WT) PFN1. These studies uncovered differential binding between two ALS-linked PFN1 variants, G118V and M114T, and select formin proteins. Furthermore, both variants augmented formin-mediated actin assembly relative to PFN1 WT. Molecular dynamics simulations revealed mutation-induced changes in the internal dynamic couplings within an alpha helix of PFN1 that directly contacts both actin and polyproline, as well as structural fluctuations within the actin- and polyproline-binding regions of PFN1. These data indicate that ALS-PFN1 variants have the potential for heightened flexibility in the context of the ternary actin-PFN1-polyproline complex during actin assembly. Conversely, PFN1 C71G was more severely destabilized than the other PFN1 variants, resulting in reduced protein expression in both transfected and ALS patient lymphoblast cell lines. Moreover, this variant exhibited loss-of-function phenotypes in the context of actin assembly. Perturbations in actin dynamics and assembly can therefore result from ALS-linked mutations in PFN1. However, ALS-PFN1 variants may dysregulate actin polymerization through different mechanisms that depend upon the solubility and stability of the mutant protein.
丝状肌动蛋白结合蛋白 1(PFN1)通过与单体肌动蛋白和富含多脯氨酸基序的蛋白结合,在调节肌动蛋白动力学方面发挥着重要作用。PFN1 中的突变与神经退行性疾病肌萎缩性侧索硬化症(ALS)有关。然而,ALS 相关突变是否影响 PFN1 的功能仍不清楚。为了解决这个问题,我们在哺乳动物细胞中采用了一种无偏的蛋白质组学分析方法,以鉴定与突变型和野生型(WT)PFN1 差异相互作用的蛋白。这些研究揭示了两种与 ALS 相关的 PFN1 变体(G118V 和 M114T)与特定的formin 蛋白之间的差异结合。此外,与 PFN1 WT 相比,这两种变体均增强了formin 介导的肌动蛋白组装。分子动力学模拟揭示了突变诱导的 PFN1 内部动态偶联变化,该变化直接与肌动蛋白和多脯氨酸相互作用,以及 PFN1 的肌动蛋白和多脯氨酸结合区域的结构波动。这些数据表明,在肌动蛋白组装过程中,ALS-PFN1 变体在与三元肌动蛋白-PFN1-多脯氨酸复合物相关的情况下具有更高的灵活性潜力。相反,PFN1 C71G 比其他 PFN1 变体更容易失稳,导致转染和 ALS 患者淋巴母细胞系中的蛋白表达减少。此外,该变体在肌动蛋白组装的背景下表现出功能丧失表型。因此,PFN1 中的 ALS 相关突变可导致肌动蛋白动力学和组装的改变。然而,ALS-PFN1 变体可能通过依赖于突变蛋白的溶解度和稳定性的不同机制来失调肌动蛋白聚合。